
PHAGEBio: Phage Biology and Antimicrobial Innovations
“We study how bacteriophages recognize and eliminate bacteria and translate this knowledge into next-generation antimicrobial strategies.”
Our mission
PHAGEBio advances phage biology and develops innovative antimicrobial solutions to combat harmful bacteria across food systems, animal health, and human medicine.
We combine scientific excellence with a culture of kindness, empowering researchers to thrive through integrity, collaboration, and respect.
Scientific focus
At PHAGEBio, we investigate the biology of bacteriophages (phages), a highly diverse class of bacterial viruses that specifically infect and kill bacteria while remaining harmless to humans and animals. Our research is driven by the fundamental question of how phages recognize, interact with, and ultimately eliminate their specific bacterial hosts.
We identify genetic factors that determine phage host specificity, particularly the receptor-binding proteins that facilitate the initial interaction between phages and bacterial surfaces. By exploring these molecular mechanisms, we aim to understand how phages selectively target bacteria.
We explore the phage dark matter: a vast and largely uncharacterized repertoire of phage-encoded proteins that lack predicted function or homology to known protein families. This unexplored genetic pool offers an exciting opportunity to discover new biological mechanisms and molecules with previously unrecognized antimicrobial activity.
From discovery to innovation
PHAGEBio develops innovative antimicrobial strategies to combat antibiotic-resistant pathogens. We identify phage-derived proteins with antimicrobial activity and engineer them to enhance their potency and target spectrum. By studying their mode of action, we uncover new bacterial susceptibilities and inform the design of next-generation antimicrobials for WHO-priority pathogens.
Phage therapy and applications
We utilize phages as therapeutic agents in phage therapy, providing a promising alternative to conventional antibiotics by selectively targeting pathogenic bacteria while preserving beneficial microbiota. Our research focuses on effective phage deployment in animal production, food systems, and human infections.
By leveraging our understanding of receptor-binding specificity and phage infection processes, we design high-efficiency phage cocktails and engineer phages with broader host ranges and improved antibacterial activity to enhance the effectiveness of phage-based interventions in complex biological environments.
Our approaches
Our research combines experimental and computational methods to explore phage biology. By integrating large collections of bacteriophages with molecular studies, we connect genotype to phenotype across diverse phage systems.
Structural bioinformatics helps us understand protein functions, host recognition, and bacterial killing mechanisms, aiding in the design of novel antimicrobial molecules and engineered phage-derived peptides with improved performance.
We also focus on phage engineering to enhance properties like host range and stability. Our efforts are bolstered by a network of international academic collaborators and industrial partners, facilitating the translation of discoveries into practical antimicrobial applications.
Pathogen focus
PHAGEBio focuses on bacterial species of major global concern, including WHO priority pathogens such as Salmonella, Escherichia coli, and Campylobacter, as well as a broad range of antibiotic-resistant bacteria. By targeting these organisms, our work directly contributes to addressing critical challenges in food safety, animal health, and human medicine.
Click on the project line to read more.
BARE: Biocontrol of Antibiotic REsistant bacteria
CAMPACT: Innovative solutions to combat Campylobacter in the poultry meat production chain
DISCOVER: Phage-guided discovery of novel antibacterial targets
INTRALYTIX: Phage-host interaction in Campylobacter
INNOLYSINS: Novel antibacterials against Salmonella
NIH: Bacteriophage biology and engineering of E. coli phages
S. DUBLIN: Target biocontrol strategy to combat Salmonella Dublin in dairy cattle
Are you looking for a bachelor or master project?
We are always interested in recruiting students from all Universities for bachelor's and master's projects in veterinary medicine, biology, biology-biotechnology, bioinformatics, food science, and others.
Contact us for more information (Lone Brøndsted lobr@sund.ku.dk, Martine C.H. Sørensen mcp@sund.ku.dk) or see here for project ideas.
![]() |
Group Leader & Principal InvestigatorProfessor Lone Brøndsted President of the International Society of Viruses of Microorganisms
|
![]() |
Principal InvestigatorAssociate Professor Martine C. H. Sørensen Organizing committee of https://www.phagedenmark.com
|
Group members
| Name | Title | Phone | |
|---|---|---|---|
| Brøndsted, Lone | Professor | +4535332756 | |
| Lampadariou, Stefanos | PhD Fellow | +4535320635 | |
| Leon Quezada, Rayen Ignacia | Postdoc | +4535335418 | |
| Lutz, Veronika Theresa | Academic Research Staff | ||
| Sørensen, Martine Camilla Holst | Associate Professor | +4535336454 | |
| Sørensen, Anders Nørgaard | Postdoc | ||
| Tadesse, Michaël Dagne | Postdoc | +4535322718 | |
| Van Overfelt, Saar Sabine F | PhD Fellow | +4535329034 | |
| Winther, Jonathan Emil Pasch | PhD Fellow |











